LC
AMED

Lindbrook Capital’s Amedisys AMED Stock Holding History

Lindbrook Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$83.7K Buy
904
+647
+252% +$59.6K 0.01% 746
2024
Q4 		$23.3K Buy
257
+21
+9% +$1.93K ﹤0.01% 1199
2024
Q3 		$22.8K Sell
236
-88
-27% -$8.59K ﹤0.01% 1223
2024
Q2 		$29.7K Buy
324
+98
+43% +$9.09K ﹤0.01% 1023
2024
Q1 		$20.8K Buy
226
+16
+8% +$1.5K ﹤0.01% 1194
2023
Q4 		$20K Sell
210
-4
-2% -$374 ﹤0.01% 1173
2023
Q3 		$20K Buy
214
+6
+3% +$554 ﹤0.01% 1063
2023
Q2 		$19K Buy
208
+129
+163% +$10.6K ﹤0.01% 1122
2023
Q1 		$5.81K Buy
79
+65
+464% +$5.62K ﹤0.01% 1791
2022
Q4 		$1.17K Sell
14
-65
-82% -$5.86K ﹤0.01% 2427
2022
Q3 		$8K Buy
+79
New +$9.42K ﹤0.01% 1399
2022
Q2 		– Sell
-20
Closed -$2.56K – 2468
2022
Q1 		$3K Buy
20
+6
+43% +$896 ﹤0.01% 1777
2021
Q4 		$2K Buy
14
+6
+75% +$964 ﹤0.01% 1739
2021
Q3 		$1K Buy
+8
New +$1.66K ﹤0.01% 1666
2021
Q2 		– Sell
-2
Closed -$1K – 1903
2021
Q1 		$1K Buy
+2
New +$564 ﹤0.01% 1660
2020
Q4 		– Sell
-2
Closed – – 1768
2020
Q3 		$0 Buy
+2
New +$455 ﹤0.01% 1735
2020
Q2 		– Sell
-12
Closed -$2K – 1711
2020
Q1 		$2K Buy
+12
New +$2.13K ﹤0.01% 1261

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Lindbrook Capital's AMED Position: Q1 2025 in Review

Lindbrook Capital increased its Amedisys (AMED) stake by 252% in Q1 2025, buying an estimated $59.6K and bringing the position to 904 shares worth $83.7K. The position accounts for 0.01% of the portfolio, ranked #746.

Lindbrook Capital first reported a position in AMED in Q1 2020 and has held it in 17 quarters since. 305 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Lindbrook Capital held 904 shares of Amedisys worth $83.7K as of Q1 2025.
  • Lindbrook Capital bought 647 Amedisys shares in Q1 2025, an estimated $59.6K.
  • Amedisys made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #746 holding.
  • Lindbrook Capital first reported a position in Amedisys in Q1 2020 and has held it in 17 quarters since.
  • 305 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.